Dipna Pharmachem

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MC401013
  • NSEID:
  • BSEID: 543594
INR
12.40
-0.4 (-3.13%)
BSENSE

Feb 10

BSE+NSE Vol: 33000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -23.99% vs 64.46% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 0.17% vs 46.33% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 0.98% vs 108.73% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -10.25% vs 19.02% in Mar 2024

Compare Profit and Loss Results of Dipna Pharmachem
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
124.00
89.00
35.00
39.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
124.00
89.00
35.00
39.33%
Expenditure (Ex Depriciation)
Stock Adjustments
9.00
-3.00
12.00
400.00%
Raw Materials Consumed
103.00
63.00
40.00
63.49%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
0.00
14.00
-14.00
-100.00%
Operating Expenses
0.00
1.00
-1.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
6.00
-6.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
121.00
91.00
30.00
32.97%
Operating Profit (PBDIT) excl Other Income
3.00
-1.00
4.00
400.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
3.00
0.00
3.00
0%
Interest
2.00
7.00
-5.00
-71.43%
Profit before Depriciation and Tax
1.00
-6.00
7.00
116.67%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
1.00
-12.00
13.00
108.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
-12.00
13.00
108.33%
Provision for Tax
0.00
-2.00
2.00
100.00%
Profit After Tax
0.00
-10.00
10.00
100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
59.00
-57.00
-96.61%
Profit Available for appropriations
3.00
48.00
-45.00
-93.75%
Appropriations
3.00
48.00
-45.00
-93.75%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.41
-7.86
8.27
105.22%
Profit And Loss - Net Sales
Net Sales 124.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -23.99% vs 64.46% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.17% vs 46.33% in Mar 2024

Profit And Loss - Interest
Interest 2.02 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.98% vs 108.73% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -10.25% vs 19.02% in Mar 2024